The problem of infertility is growing by leaps and bounds in the modern world, with an estimated 15-20 percent of Indian couples in the reproductive age unable to have a child.
Bangalore, 12th June, 2014: (PressReleasePoint) The problem of infertility is growing by leaps and bounds in the modern world, with an estimated 15-20 percent of Indian couples in the reproductive age unable to have a child.
Infertility as a health condition has traditionally been considered the exclusive preserve of women. However, medical experts say it affects men in equal measure.
According to the WHO, infertility is a disease of the reproductive system which is defined as the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse.
There are numerous reasons for infertility. Some of these are medical, while others are related to lifestyle. The main medical causes include the following factors:
Diminishing egg reserves in women. (About 6-8 percent of women have no egg reserves left by the time they reach 35 years, making conception impossible)
Pelvic infections, which often go unnoticed
Premature ovarian failure
Poly Cystic Ovarian Disease (PCOD)
Endometriosis (A painful disorder in which tissue that normally lines the inside of the uterus begins to grow outside it.)
Dr. Manjunath CS, Clinical Director, Nova IVI Fertility explained, “Our lifestyle patterns are largely responsible for the rising incidence of infertility. A sedentary way of living, late marriages, stress, obesity, and excessive drinking and smoking are some of the reasons. Bad eating habits such as the consumption of oily or junk food also influence one’s fertility potential.”
That was the bad news. The good news is that with the availability of state-of-the-art assisted reproductive technologies (ARTs), couples facing infertility can now fulfil their dream of becoming parents. Some of the ART procedures available in India include:
Intra-cytoplasmic Sperm Injection (ICSI): In this, a sperm is directly injected into the egg for fertilization. Once the egg fertilises, it is planted into the womb.
Intracytoplasmic Morphologically Selected Sperm Injection (IMSI): This is an upgrade of ICSI. It enables an embryologist to carry out fertilization of egg by using a high-powered microscope to select sperm cells with the best morphological quality.
Pre-Implantation Genetic Diagnosis (PGD): This is used to check for genetic disorders like Down syndrome, cystic fibrosis, and muscular dystrophy in an embryo. Once the problem is diagnosed, appropriate treatment can be given to increase the chances of conception.
Endometrial Receptivity Array: This state-of-the-art molecular tool allows doctors to diagnose whether the uterus is receptive or not for embryo implantation. It is meant for patients with a history of repeated implantation failure.
Embryoscope: This is an IVF incubator with a built-in camera that tracks the development of an embryo with a set of images. It enables the doctors to monitor any abnormalities or deformities.
“ While these are the various infertility treatments now available, about 70 percent of all cases require only minimum assistance and can be treated by using egg-producing drugs or Intra Uterine Insemination (IUI),” added Dr. Manjunath CS.
Advanced reproductive treatments like ICSI are expensive due to the high cost of drugs. They are also not covered by any insurance scheme in India.
About Nova Medical Centers:
Nova Medical Centers is the parent company of Nova Specialty Hospitals and Nova IVI Fertility. It currently operates 10 specialty surgery hospitals and 9 fertility centers, with 1 polyclinic in Muscat, Oman. Nova was co-founded by Suresh Soni and renowned shoulder surgeon Dr. Mahesh Reddy, along with the GTI Group, based on a “doctor-owned and doctor-managed” concept enabling doctors to have a sense of ownership and a long-term association with the company. This concept also allows world-class doctors to deliver the best possible patient care in a hassle-free environment.
Established in 2009, Nova Specialty Hospitals’ mission is to provide world-class surgical care that is accessible and at an affordable cost. Having pioneered the concept of short-stay surgical care in India, Nova focuses on providing the finest quality care for patients from specialized doctors while increasing operating efficiency.
Nova IVI Fertility is a joint venture between Nova Pulse, India, and IVI, Spain, introducing the same exceptional standard of processes, protocols and policies to deliver the most sophisticated Assisted Reproductive Technology (ART) in India.
Nova’s vision is to create a novel institution that stands for excellence in healthcare services by providing the best patient experience and is an international reference for clinical outcomes, by adopting the latest advances in medical sciences, technology and an innovative business model.